Učitavanje...
Guadecitabine (SGI‐110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin
Promoter DNA hypermethylation is an important biomarker of hepatocellular carcinoma (HCC), supporting the potential utility of demethylating agents in this disease. Guadecitabine (SGI‐110) is a second‐generation hypomethylating agent formulated as a dinucleotide of decitabine and deoxyguanosine that...
Spremljeno u:
| Izdano u: | Mol Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528722/ https://ncbi.nlm.nih.gov/pubmed/26160429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.06.002 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|